ASHLEY MCDONOUGH: Open Payments
NPI 1548964638 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 44 payments from 11 companies in 2025. Trend: 2023 $258 · 2024 $748 · 2025 $924
Food & beverage: $833Education: $91
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $288 |
| ABBVIE INC. | 10 | $154 |
| LEO Pharma Inc. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $65 |
| Arcutis Biotherapeutics, Inc. | 4 | $65 |
| Galderma Laboratories, L.P. | 2 | $61 |
| STRATA Skin Sciences, Inc. | 4 | $34 |
| Incyte Corporation | 1 | $26 |
| UCB, Inc. | 1 | $23 |
Products named: DUPIXENT, SKYRIZI, ADBRY, Zoryve, NEMLUVIO, BLU-U, XTRAC, OPZELURA.
Industry payments across MD — which companies pay providers there.
